Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Combined effect of ALK and MEK inhibitors in EML4―ALK-positive non-small-cell lung cancer cellsTANIZAKI, J ; OKAMOTO, I ; NAKAGAWA, K ; TAKEZAWA, K ; SAKAI, K ; AZUMA, K ; KUWATA, K ; YAMAGUCHI, H ; HATASHITA, E ; NISHIO, K ; JANNE, P. ABritish journal of cancer, 2012-02, Vol.106 (4), p.763-767 [Periódico revisado por pares]Basingstoke: Nature Publishing GroupTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Activin A inhibits vascular endothelial cell growth and suppresses tumour angiogenesis in gastric cancerKANEDA, H ; ARAO, T ; TANAKA, K ; YANAGIHARA, K ; YAMADA, Y ; OKAMOTO, I ; NAKAGAWA, K ; NISHIO, K ; MATSUMOTO, K ; DE VELASCO, M. A ; TAMURA, D ; AOMATSU, K ; KUDO, K ; SAKAI, K ; NAGAI, T ; FUJITA, YBritish journal of cancer, 2011-10, Vol.105 (8), p.1210-1217 [Periódico revisado por pares]Basingstoke: Nature Publishing GroupTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
The prognostic significance of vasohibin-1 expression in patients with prostate cancerKOSAKA, T ; MIYAZAKI, Y ; SATO, Y ; OYA, M ; MIYAJIMA, A ; MIKAMI, S ; HAYASHI, Y ; TANAKA, N ; NAGATA, H ; KIKUCHI, E ; NAKAGAWA, K ; OKADA, YBritish journal of cancer, 2013-05, Vol.108 (10), p.2123-2129 [Periódico revisado por pares]Basingstoke: Nature Publishing GroupTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patientsKoivunen, J P ; Kim, J ; Lee, J ; Rogers, A M ; Park, J O ; Zhao, X ; Naoki, K ; Okamoto, I ; Nakagawa, K ; Yeap, B Y ; Meyerson, M ; Wong, K-K ; Richards, W G ; Sugarbaker, D J ; Johnson, B E ; Jänne, P ABritish journal of cancer, 2008-07, Vol.99 (2), p.245-252 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Enhancement of the antitumor activity of ionising radiation by nimotuzumab, a humanised monoclonal antibody to the epidermal growth factor receptor, in non-small cell lung cancer cell lines of differing epidermal growth factor receptor statusAKASHI, Y ; OKAMOTO, I ; NAKAGAWA, K ; IWASA, T ; YOSHIDA, T ; SUZUKI, M ; HATASHITA, E ; YAMADA, Y ; SATOH, T ; FUKUOKA, M ; ONO, KBritish journal of cancer, 2008-02, Vol.98 (4), p.749-755 [Periódico revisado por pares]Basingstoke: Nature Publishing GroupTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Marked anti-tumour activity of the combination of YM155, a novel survivin suppressant, and platinum-based drugsIWASA, T ; OKAMOTO, I ; KUWATA, K ; FUKUOKA, M ; NAKAGAWA, K ; TAKEZAWA, K ; YAMANAKA, K ; NAKAHARA, T ; KITA, A ; KOUTOKU, H ; SASAMATA, M ; HATASHITA, E ; YAMADA, YBritish journal of cancer, 2010-06, Vol.103 (1), p.36-42 [Periódico revisado por pares]Basingstoke: Nature Publishing GroupTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Genetic instability in lung cancer: concurrent analysis of chromosomal, mini- and microsatellite instability and loss of heterozygosityNINOMIYA, H ; NOMURA, K ; SATOH, Y ; OKUMURA, S ; NAKAGAWA, K ; FUJIWARA, M ; TSUCHIYA, E ; ISHIKAWA, YBritish journal of cancer, 2006-05, Vol.94 (10), p.1485-1491 [Periódico revisado por pares]Basingstoke: Nature Publishing GroupTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomasUEMURA, H ; NAKAGAWA, Y ; YOSHIDA, K ; SAGA, S ; YOSHIKAWA, K ; HIRAO, Y ; OOSTERWIJK, EBritish Journal of Cancer, 1999-10, Vol.81 (4), p.741-746 [Periódico revisado por pares]Basingstoke: Nature Publishing GroupTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
A phase I study of pemetrexed (LY231514) supplemented with folate and vitamin B in Japanese patients with solid tumoursBritish journal of cancer, 2006-09, Vol.95 (6), p.677-682 [Periódico revisado por pares]Texto completo disponível |
10 |
Material Type: Artigo
|
![]() |
The expression of p73 is increased in lung cancer, independent of p53 gene alterationTOKUCHI, Y ; HASHIMOTO, T ; KAWAKAMI, Y ; TSUCHIYA, E ; KOBAYASHI, Y ; HAYASHI, M ; NISHIDA, K ; HAYASHI, S ; IMAI, K ; NAKACHI, K ; ISHIKAWA, Y ; NAKAGAWA, KBritish journal of cancer, 1999-07, Vol.80 (10), p.1623-1629 [Periódico revisado por pares]Basingstoke: Nature Publishing GroupTexto completo disponível |